{"DataElement":{"publicId":"2797671","version":"2","preferredName":"Acute Graft Versus Host Disease Liver Involvement Maximum Severity Type","preferredDefinition":"A description of the maximum severity of acute graft versus host disease liver involvement.","longName":"2797648v1.0:2797650v1.5","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2797648","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Involvement Maximum Severity","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate._To have a connection by participation or association or use; sharing in an activity or process._The largest possible quantity or degree._Used of the degree of something undesirable e.g. pain or weather; also, strictness.","longName":"AGVHD_LV_IN_MX_SV","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2797646","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Involvement","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.:To have a connection by participation or association or use; sharing in an activity or process.","longName":"C4980:C12392:C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF59D42-C7B3-3B75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"ONEDATA","dateModified":"2008-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2797604","version":"1","preferredName":"Maximum Severity","preferredDefinition":"the largest possible quantity or degree.:Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"C25564:C25676","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF3F82E-0B53-6059-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"ONEDATA","dateModified":"2008-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF59D42-C7C1-3B75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2797650","version":"1.5","preferredName":"Acute Graft Versus Host Disease Liver Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.","longName":"2797650v1.5","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"68","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 4","valueDescription":"AGVHD Liver Stage 4","ValueMeaning":{"publicId":"5132191","version":"1","preferredName":"AGVHD Liver Stage 4","longName":"5132191","preferredDefinition":"Bilirubin > 15.0 mg/dL (> 256 micromol/L)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-14E7-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-1500-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 3","valueDescription":"AGVHD Liver Stage 3","ValueMeaning":{"publicId":"5132192","version":"1","preferredName":"AGVHD Liver Stage 3","longName":"5132192","preferredDefinition":"Bilirubin 6.1-15.0 mg/dL (104-256 micromol/L)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-150A-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-1523-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 2","valueDescription":"AGVHD Liver Stage 2","ValueMeaning":{"publicId":"5132193","version":"1","preferredName":"AGVHD Liver Stage 2","longName":"5132193","preferredDefinition":"Bilirubin 3.1-6.0 mg/dL (53-103 micromol/L)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-152D-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-1546-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 1","valueDescription":"AGVHD Liver Stage 1","ValueMeaning":{"publicId":"5132194","version":"1","preferredName":"AGVHD Liver Stage 1","longName":"5132194","preferredDefinition":"Bilirubin 2.0-3.0 mg/dL (34-52 micromol/L)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-1550-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-1569-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 0","valueDescription":"AGVHD Liver Stage 0","ValueMeaning":{"publicId":"5132195","version":"1","preferredName":"AGVHD Liver Stage 0","longName":"5132195","preferredDefinition":"No liver acute GVHD / bilirubin < 2.0 mg/dL (< 34 micromol/L)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C874053-1573-16D8-E050-BB89AD437237","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C874053-158C-16D8-E050-BB89AD437237","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2797649","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.:Severity; used of the degree of something undesirable e.g. pain or weather.:Type; a subdivision of a particular kind of thing.","longName":"C4980:C12392:C25676:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF59D42-C7E2-3B75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-05","modifiedBy":"ONEDATA","dateModified":"2008-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23428223-ECB4-0C35-E050-BB89AD430FC5","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"},{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"HPST_AGHD_agvhd_max_stge_liv","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"TPST_GVHD_agvhd_max_stge_liv","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"List the maximum severity of liver involvement:","type":"Alternate Question Text","description":"List the maximum severity of liver involvement:","url":null,"context":"NHLBI"},{"name":"What was the maximum severity","type":"Preferred Question Text","description":"What was the maximum severity of acute graft versus host disease liver involvement?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2797671","type":"BRIDG Mapping Path","description":"PerformedObservation > PerformedClinicalInterpretation.value WHERE PerformedObservation > DefinedObservation.nameCode = \"assess severity\" AND PerformedObservation.targetAnatomicSiteCode = \"upper intestinal tract\" AND PerformedObservation > AssessedResultRelationship > PerformedDiagnosis.value = \"GVHD\" AND PerformedDiagnosis.diseaseStatusCode = \"Acute\" AND AssessedResultRelationship.typeCode = \"assessment\"","url":null,"context":"NHLBI"},{"name":"Liver","type":"Alternate Question Text","description":"Liver","url":null,"context":"NHLBI"},{"name":"Liver","type":"Application Standard Question Text","description":"Liver","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2343D90C-F0C2-7371-E050-BB89AD431122","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"KUMMEROA","dateModified":"2019-06-06","changeDescription":". Added Field Name for 2450. AK 6/6/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}